Details of the Drug Formulaction

General Information of Drug Formulation (ID: F00029)

• Formulation Name: Acamprosate 333 mg tablet
• Company: Avera McKennan Hospital; Glenmark Pharmaceutials

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Acamprosate	(DMO381I)	Alcohol dependence	6C40.2	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Crospovidone	(E00626)	Not Available	Disintegrant
Magnesium silicate	(E00596)	72941442	Anticaking agent; Glidant; Lubricant
Magnesium stearate	(E00208)	11177	lubricant
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant